iTeos Therapeutics, Inc.
ITOSDelisted Aug 29, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001808865
iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in iTeos Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 137
- −13 vs. Q3 2024
- Shares held
- 34.1M
- −2.29M (−6.3%) vs. Q3 2024
- Total value
- $262.2M
- −$109.7M (−29.5%) vs. Q3 2024
- New holders
- 27
- 50 more added
- Sold out
- 40
- 44 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $2.35K |
| Q2 2025 | 137 | $377.0M |
| Q1 2025 | 132 | $220.7M |
| Q4 2024 | 137 | $262.2M |
| Q3 2024 | 151 | $373.3M |
| Q2 2024 | 139 | $536.8M |
| Q1 2024 | 136 | $471.2M |
| Q4 2023 | 138 | $383.4M |
| Q3 2023 | 144 | $388.6M |
| Q2 2023 | 146 | $460.4M |
| Q1 2023 | 153 | $488.9M |
| Q4 2022 | 146 | $707.3M |
| Q3 2022 | 143 | $698.2M |
| Q2 2022 | 153 | $768.1M |
| Q1 2022 | 159 | $1.17B |
| Q4 2021 | 118 | $1.55B |
| Q3 2021 | 77 | $841.3M |
| Q2 2021 | 83 | $755.8M |
| Q1 2021 | 81 | $1.03B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding iTeos Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 132,894 | $1.02M | 0.00% | +19,683+17.4% | Added |
| Jane Street Group, LLC | 135,031 | $1.04M | 0.00% | +116,184+616.5% | Added |
| Kennedy Capital Management, Inc. | 138,591 | $1.06M | 0.02% | −16,844−10.8% | Reduced |
| Raymond James Financial Inc | 150,967 | $1.16M | 0.00% | +150,967 | New |
| Trexquant Investment LP | 179,966 | $1.38M | 0.02% | +130,960+267.2% | Added |
| DAFNA Capital Management LLC | 188,347 | $1.45M | 0.37% | +26,763+16.6% | Added |
| Qube Research & Technologies Ltd | 194,953 | $1.50M | 0.00% | +19,362+11.0% | Added |
| Charles Schwab Investment Management Inc | 199,196 | $1.53M | 0.00% | −22,939−10.3% | Reduced |
| Ameriprise Financial Inc | 205,188 | $1.58M | 0.00% | +143,672+233.6% | Added |
| Eversept Partners, LP | 220,196 | $1.69M | 0.17% | +220,196 | New |
| Tang Capital Management LLC | 221,716 | $1.70M | 0.11% | −2,186,084−90.8% | Reduced |
| Prudential Financial Inc | 232,091 | $1.78M | 0.00% | −21,200−8.4% | Reduced |
| Susquehanna International Group, LLP | 233,876 | $1.80M | 0.00% | +214,336+1,096.9% | Added |
| Morgan Stanley | 250,617 | $1.92M | 0.00% | −250,749−50.0% | Reduced |
| Northern Trust Corp | 259,737 | $1.99M | 0.00% | +7,881+3.1% | Added |
| Almitas Capital LLC | 275,120 | $2.11M | 0.46% | +275,120 | New |
| Millennium Management LLC | 411,072 | $3.16M | 0.00% | +373,999+1,008.8% | Added |
| Acadian Asset Management LLC | 470,146 | $3.61M | 0.01% | +453,245+2,681.8% | Added |
| Caption Management, LLC | 509,829 | $3.92M | 0.16% | +509,829 | New |
| State Street Corp | 585,936 | $4.50M | 0.00% | −589,417−50.1% | Reduced |
| Geode Capital Management, LLC | 644,901 | $4.95M | 0.00% | +4,551+0.7% | Added |
| Goldman Sachs Group Inc | 730,491 | $5.61M | 0.00% | −182,522−20.0% | Reduced |
| Renaissance Technologies LLC | 837,200 | $6.43M | 0.01% | +300,800+56.1% | Added |
| Citigroup Inc | 853,781 | $6.56M | 0.01% | +833,589+4,128.3% | Added |
| Vestal Point Capital, LP | 900,000 | $6.91M | 0.41% | −125,000−12.2% | Reduced |
| 683 Capital Management, LLC | 918,117 | $7.05M | 0.69% | −652,171−41.5% | Reduced |
| Jacobs Levy Equity Management, Inc | 922,134 | $7.08M | 0.03% | +716,271+347.9% | Added |
| Boxer Capital Management, LLC | 946,915 | $7.27M | 0.62% | +946,915 | New |
| Dimensional Fund Advisors LP | 1,210,080 | $9.29M | 0.00% | +163,880+15.7% | Added |
| Citadel Advisors LLC | 1,432,262 | $11.0M | 0.01% | +196,003+15.9% | Added |
| Vanguard Group Inc | 1,634,029 | $12.5M | 0.00% | −22,781−1.4% | Reduced |
| MPM Oncology Impact Management LP | 1,745,943 | $13.4M | 1.90% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,068,796 | $15.9M | 0.00% | +1,601,477+342.7% | Added |
| Ra Capital Management, L.P. | 2,092,259 | $16.1M | 0.21% | −1,092,452−34.3% | Reduced |
| BVF Inc | 2,325,000 | $17.9M | 0.61% | +2,325,000 | New |
| MPM Asset Management LLC | 2,738,785 | $21.0M | 16.91% | 00.0% | Unchanged |
| BlackRock, Inc. | 3,801,509 | $29.2M | 0.00% | −81,040−2.1% | Reduced |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −2,946,915−100.0% | Sold out |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −1,608,616−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −769,213−100.0% | Sold out |
| K2 Principal Fund, L.P. | 0 | $0 | 0.00% | −534,951−100.0% | Sold out |
| Saturn V Capital Management LLC | 0 | $0 | 0.00% | −195,704−100.0% | Sold out |
| Clearline Capital LP | 0 | $0 | 0.00% | −167,417−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −122,697−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −67,723−100.0% | Sold out |
| Susquehanna Portfolio Strategies, LLC | 0 | $0 | 0.00% | −62,062−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −57,743−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −56,507−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −49,835−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −40,182−100.0% | Sold out |
| Swiss National Bank | 0 | $0 | 0.00% | −40,100−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −37,900−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −34,367−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −25,787−100.0% | Sold out |
| Massachusetts Financial Services Co | 0 | $0 | 0.00% | −23,662−100.0% | Sold out |
| Jupiter Asset Management Ltd | 0 | $0 | 0.00% | −23,133−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −22,601−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −20,332−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −19,636−100.0% | Sold out |
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −15,650−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −14,801−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −11,649−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −3,320−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −3,117−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Great West Life Assurance Co | 0 | $0 | 0.00% | −785−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −227−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −116−100.0% | Sold out |
| Toth Financial Advisory Corp | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −95−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −54−100.0% | Sold out |
| Eagle Asset Management Inc | – | – | – | – | Not filed |